Tuesday, October 4, 2016

Paliperidone




In the US, Paliperidone (paliperidone systemic) is a member of the drug class atypical antipsychotics and is used to treat Bipolar Disorder, Depression, Schizoaffective Disorder and Schizophrenia.

US matches:

  • Paliperidone

  • Paliperidone Extended-Release Tablets

  • Paliperidone Intramuscular

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N05AX13

CAS registry number (Chemical Abstracts Service)

0144598-75-4

Chemical Formula

C23-H27-F-N4-O3

Molecular Weight

426

Therapeutic Categories

Neuroleptic

Dopamine D2 antagonist

Chemical Names

(RS)-3-{2-[4-(6-Fluor-1,2-benzisoxazol-3-yl)piperidino]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-on (IUPAC)

(±)-3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one (WHO)

Foreign Names

  • Paliperidonum (Latin)
  • Paliperidon (German)
  • Paliperidone (French)
  • Paliperidona (Spanish)

Generic Names

  • Paliperidone (OS: USAN)
  • 9-Hydroxyrisperidone (IS)
  • ELAN C3 (IS)
  • R-76477 (IS: JohnsonJohns)
  • RO-92670 (IS)

Brand Names

  • Invega Sustenna
    Johnson & Johnson, United States


  • Invega
    Janssen, Australia; Janssen, Germany; Janssen, Spain; Janssen, Greece; Janssen, Hungary; Janssen, Ireland; Janssen, Italy; Janssen, Luxembourg; Janssen, Netherlands; Janssen-Cilag, Switzerland; Janssen-Cilag, Denmark; Janssen-Cilag, United Kingdom; Janssen-Cilag, Indonesia; Janssen-Cilag, Singapore; Janssen-Cilag International, Austria; Janssen-Ortho Inc., Canada; Johnson & Johnson, Croatia (Hrvatska); Ortho-McNeil, United States; Xian-Janssen, China


  • INVEGA
    Janssen-Cilag, Sweden

International Drug Name Search

Glossary

IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

No comments:

Post a Comment